New FDA-Approved Device Uses Electric Fields to Treat Pancreatic Cancer

discovermagazine - Learn more about the newly approved wearable treatment that disrupts pancreatic cancer tumor growth while letting patients continue daily life at home.

AI Summary: The FDA approved a wearable device that delivers alternating electric fields to disrupt pancreatic tumor growth, letting patients remain ambulatory while receiving treatment. Clinicians hail the noninvasive approach as a new adjunct to standard care, aiming to slow progression in a cancer that’s notoriously hard to treat — and yes, it literally plugs into hope.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

AI tool helps choose pancreatic chemotherapy, shows clinical promise / 2 months

DeepRare AI beats clinicians at diagnosing rare diseases / 3 months

Grail’s Galleri blood test misses UK study goal; investor jitters / 3 months

AI liquid biopsy detects silent liver disease years earlier / 2 months

Major study finds GRAIL multi‑cancer blood test did not detect cancers earlier / 3 months

Independent study flags safety issues in ChatGPT Health triage / 3 months

Plasma p‑tau217 blood test predicts Alzheimer’s symptoms years ahead / 3 months